Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| plasmacytoid dendritic cell | 15 studies | 33% ± 12% | |
| pericyte | 14 studies | 33% ± 10% | |
| astrocyte | 8 studies | 31% ± 14% | |
| macrophage | 8 studies | 28% ± 11% | |
| mast cell | 6 studies | 22% ± 4% | |
| dendritic cell | 6 studies | 25% ± 8% | |
| endothelial cell | 5 studies | 28% ± 5% | |
| conventional dendritic cell | 4 studies | 20% ± 4% | |
| glutamatergic neuron | 4 studies | 41% ± 20% | |
| oligodendrocyte precursor cell | 4 studies | 23% ± 5% | |
| Mueller cell | 3 studies | 41% ± 13% | |
| retina horizontal cell | 3 studies | 22% ± 5% | |
| GABAergic neuron | 3 studies | 27% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 37% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 98% | 535.20 | 569 / 578 | 86% | 3.59 | 988 / 1155 |
| stomach | 100% | 1146.28 | 358 / 359 | 78% | 4.07 | 224 / 286 |
| breast | 96% | 349.70 | 440 / 459 | 81% | 2.31 | 901 / 1118 |
| brain | 84% | 207.09 | 2220 / 2642 | 92% | 2.62 | 651 / 705 |
| intestine | 98% | 1005.24 | 951 / 966 | 75% | 2.84 | 393 / 527 |
| thymus | 92% | 264.32 | 604 / 653 | 77% | 2.17 | 466 / 605 |
| esophagus | 94% | 513.22 | 1355 / 1445 | 73% | 2.41 | 134 / 183 |
| bladder | 90% | 1079.62 | 19 / 21 | 57% | 1.84 | 287 / 504 |
| skin | 61% | 119.44 | 1111 / 1809 | 48% | 1.38 | 228 / 472 |
| uterus | 57% | 151.51 | 97 / 170 | 40% | 1.43 | 184 / 459 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 10.69 | 28 / 29 |
| adipose | 93% | 484.98 | 1125 / 1204 | 0% | 0 | 0 / 0 |
| kidney | 22% | 26.67 | 20 / 89 | 68% | 4.24 | 615 / 901 |
| muscle | 88% | 154.48 | 705 / 803 | 0% | 0 | 0 / 0 |
| heart | 82% | 175.13 | 704 / 861 | 0% | 0 | 0 / 0 |
| spleen | 63% | 88.36 | 153 / 241 | 0% | 0 | 0 / 0 |
| pancreas | 0% | 0.23 | 1 / 328 | 62% | 2.34 | 111 / 178 |
| tonsil | 0% | 0 | 0 / 0 | 60% | 1.82 | 27 / 45 |
| blood vessel | 58% | 103.00 | 771 / 1335 | 0% | 0 | 0 / 0 |
| adrenal gland | 10% | 9.90 | 25 / 258 | 41% | 0.89 | 95 / 230 |
| prostate | 24% | 32.13 | 60 / 245 | 24% | 0.44 | 121 / 502 |
| ovary | 24% | 44.07 | 43 / 180 | 17% | 0.35 | 73 / 430 |
| peripheral blood | 29% | 67.11 | 267 / 929 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 20% | 0.41 | 82 / 406 |
| eye | 0% | 0 | 0 / 0 | 8% | 0.09 | 6 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0035589 | Biological process | G protein-coupled purinergic nucleotide receptor signaling pathway |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0045029 | Molecular function | G protein-coupled UDP receptor activity |
| GO_0045028 | Molecular function | G protein-coupled purinergic nucleotide receptor activity |
| Gene name | P2RY14 |
| Protein name | Purinergic receptor P2Y G-protein coupled 14 transcript variant 2 (Purinergic receptor P2Y, G-protein coupled, 14, isoform CRA_a) (cDNA FLJ75398, highly similar to Homo sapiens purinergic receptor P2Y, G-protein coupled, 14, mRNA) Purinergic receptor P2Y14 P2Y purinoceptor 14 (P2Y14) (G-protein coupled receptor 105) (UDP-glucose receptor) |
| Synonyms | GPR105 hCG_20914 KIAA0001 |
| Description | FUNCTION: Receptor for UDP-glucose and other UDP-sugar coupled to G-proteins. Not activated by ATP, ADP, UTP or ATP. . |
| Accessions | A5JUU3 Q15391 ENST00000494668.1 ENST00000424796.6 ENST00000309170.8 C9JAB5 |